Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

5.23
+0.05000.97%
Volume:364.30K
Turnover:1.92M
Market Cap:337.70M
PE:-5.34
High:5.38
Open:5.20
Low:5.20
Close:5.18
52wk High:10.08
52wk Low:3.86
Shares:64.57M
Float Shares:49.21M
Volume Ratio:0.71
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9796
EPS(LYR):-1.2729
ROE:-52.15%
ROA:-32.77%
PB:1.77
PE(LYR):-4.11

Loading ...

Immuneering announces updated data from Phase 2a trial for atebimetinib

TIPRANKS
·
Apr 22

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and McKesson (MCK)

TIPRANKS
·
Apr 21

Immuneering announces annual shareholder meeting webcast

Reuters
·
Apr 21

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

GlobeNewswire
·
Apr 20

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Immuneering (IMRX) and Maze Therapeutics, Inc. (MAZE)

TIPRANKS
·
Apr 14

Immuneering CEO to join Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 07

Immuneering to present atebimetinib ctDNA analysis at AACR Annual Meeting

Reuters
·
Mar 18

Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival

GlobeNewswire
·
Mar 18

Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)

TIPRANKS
·
Mar 12

Immuneering price target lowered to $12 from $13 at Piper Sandler

TIPRANKS
·
Mar 09

Immuneering Price Target Maintained With a $11.00/Share by Needham

Dow Jones
·
Mar 09

BUZZ-U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT

Reuters
·
Mar 07

BUZZ-U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners

Reuters
·
Mar 06

BUZZ-U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences

Reuters
·
Mar 06

Shares of Immuneering Down 1.8% Premarket After Q4 Results

THOMSON REUTERS
·
Mar 06

BUZZ-Immuneering rises as quarterly loss comes in below estimates

Reuters
·
Mar 06

Immuneering posts smaller‑than‑expected Q4 loss on reduced R&D costs

Reuters
·
Mar 06

Immuneering reports Q4 EPS (18), consensus (31c)

TIPRANKS
·
Mar 06

Immuneering sees cash runway into 2029

TIPRANKS
·
Mar 06